NA Proactive news snapshot: Algernon Pharmaceuticals, EuroLife Brands, ImagineAR, CB2 Insights …

Algernon Pharmaceuticals Inc. (CSE:AGN) (OTCQB:AGNPF), a clinical stage pharmaceutical development company, has announced that Dr. Mark Williams, its chief science officer of Algernon, will be making a presentation entitled “The Science of Ifenprodil” on a special BioPub webcast today April 29th, 2020 hosted by Dr. KSS, MD, PhD at 12.00pm EDT. The company said interested shareholders, investors, members of the media and the public can log on for a complimentary webcast of the interview. Please click the following link to join the webinar ID: 873 9720 9889: https://us02web.zoom.us/j/87397209889. Alternatively, iPhone one-tap: US: +16699009128, 87397209889# or +12532158782, 87397209889#; telephone: US: +1 669 900 9128 or +1 253 215 8782 or +1 301 715 8592 or +1 312 626 6799 or +1 346 248 7799 or +1 646 558 8656 ; International numbers available via https://us02web.zoom.us/u/kdMCg5Dbe2 EuroLife Brands Inc (CSE:EURO) (OTCMKTS:EURPF) (FSE:3CMA) has told investors it is keen to get into the mushroom superfood sector in Europe in the same way it entered the cannabis and hemp marketplace. Traditional mushrooms are rich in nutrients such as potassium, calcium, amino acids, fiber, and vitamins B & D, which are known to improve antioxidant activity in the human body. The firm cited one research report, which suggested that the medicinal mushroom market could reach US$78.8 billion by 2025, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period between 2018 and 2025. ImagineAR Inc (CSE:IP) (OTCMKTS:IPNFF) revealed Wednesday that it has won a five-year $300,000 licensing agreement to provide its augmented reality (AR) platform to custom graphics company SlapItOn for the launch of its new line of interactive products featuring athletes and celebrities. In addition to the licensing agreement, ImagineAR will earn five-year management program revenue fees which can “significantly” boost annual revenue, the Canadian augmented reality platform company said in a statement.  SlapItOn is owned by an elite group of athletes including founder CEO and National Football League All-Pro Mike Vanderjagt. Separately, ImagineAR announced the launch of a discussion forum on AGORACOM. In 2019, AGORACOM was the only small-cap marketing firm to hold a Twitter verified badge, averaging 4.2 million Twitter impressions per month. ImagineAR said the forum will serve as the company's “primary” social media platform to interact with shareholders and investors. The ImagineAR HUB is live and can be found at https://agoracom.com/ir/Imaginear CB2 Insights Inc (CSE:CBII) (OTCQB:CBIIF) said Wednesday that it has officially launched its newest division in the USA - Skylight Health Group (SHG) - which the group hopes will be a leader in Integrative Medical Services nationwide. SHG's focus will be to provide a broad array of primary and alternative healthcare services including family/specialty medicine and chronic disease. It will augment CB2 Insights'  current clinic portfolio, which has more than 30 locations in 12 states and employs over 150 staff and medical professionals. O3 Mining Inc (CVE:OIII) told shareholders on Wednesday that it has sold its remaining 24 claims on the Tortigny property in Quebec to Kenorland Minerals Ltd. The sale nets O3 a cash consideration of C$900,000 payable in four payments over three years, as well as a 2% net smelter returns (NSR) royalty over the claims. O3 has now fully divested its ownership in Tortigny in three cash-and-share transactions for a total value of around C$2.6 million. PreveCeutical Medical Inc (CSE:PREV) (OTCMKTS:PRVCF), the health sciences company developing preventative therapies, has confirmed its first peptide with promising preclinical potential as a non-addictive painkiller. The Vancouver-based company shared the news in a positive update on Wednesday on its non-addictive analgesic dynorphin pain peptide program. After shortlisting of a panel of peptides showing “promising cell-based activity” and “extended stability” in two distinct types of biological media, the program has identified its first peptide with clear "in vivo activity in a rat model” of inflammatory pain, PreveCeutical said in the statement. Royal Road Minerals Limited (CVE:RYR) (OTCMKTS:RRDMF) has struck more agreements on mining at promising gold operations in the Nariño district of Colombia - this time at the La Candelaria and San Miguel mines. In a statement, the group said its Colombian subsidiary Exploraciones Northern Colombia SAS (ENC) has struck the deals and related earn-in and option agreements with the proprietors of the two mines. ENC will receive a quarterly royalty equivalent to 3% of the doré extracted from the concessions and has been granted the sole right to carry out all exploration as well as the right to acquire 70% of the concessions, subject to certain exploration milestones. Capstone Turbine Corporation (NASDAQ:CPST) announced Wednesday that it has received a $2.6 million small business loan through the Paycheck Protection Program put in place by the Coronavirus Aid, Relief and Economic Security (CARES) Act. The microturbine producer said it put in place a business continuity plan (BCP) on March 24, under which it furloughed, reduced hours or reduced pay for 70% of its workforce. Additionally, the company’s CEO and other executive staff took a temporary 25% cut, and other managers took a 15% cut. The loan was entered into with Capstone’s banking partner, Western Alliance Bank, on April 24. BevCanna Enterprises Inc (CSE:BEV) (OTCMKTS:BVNNF) said it has strengthened its balance sheet and preserved cash amid these uncertain times by settling a debt with the issue of shares. The firm owed Naturo Group Investments Inc for a strategic advance, which was a debt of C$197,000, and so issued it with 492,750 shares at a deemed price of C$0.40. Naturo is controlled by Marcello Leone, Bevcanna's chief executive, chairman and a director. Great Bear Resources Ltd. (CVE:GBR) announced that it has obtained a final order from the Supreme Court of British Columbia dated April 28, 2020, to implement the company's previously announced plan of arrangement to reorganize its business, including the spin-off of its wholly-owned subsidiary, Great Bear Royalties Corp. The group said that substantially all of the terms and conditions of the transaction have now been met, including shareholder approval on April 23, 2020. Under the transaction, the owners of Great Bear common shares on May 4, 2020 will receive: (i) one new common share of Great Bear for each common share held; and (ii) one-fourth of a Great Bear Royalties Corp share for each common share of Great Bear held on the day before the effective date of the transaction. It added that existing common shares of Great Bear are expected to be delisted on the TSX Venture Exchange effective from the close of business on May 4, and the new common shares of Great Bear are expected to commence trading at the market opening on May 5. Great Bear Royalties shares will not be listed on a public stock exchange but will operate as a reporting issuer. The group said completion of the arrangement remains subject to the final approval of the TSX Venture Exchange. Naturally Splendid Enterprises Ltd. (CVE:NSP) (OTCMKTS:NSPDF) has announced that, due to circumstances created by the coronavirus (COVID-19) pandemic measures, the company will be delaying the filing of its annual financial statements and related management discussion and analysis for the year ended December 31, 2019, until a date that is on or before June 15, 2020. The company confirmed that no material business developments have occurred since the filing of its interim financial statements for the three and nine-month period ended September 30, 2019, and should material business developments occur the company will update shareholders accordingly. It also noted that all company executives, directors and insiders will be subject to a trading black-out policy. Fura Gems Inc. (CVE:FURA) (OTCMKTS:FUGMF) has said it will be relying on the extension granted by various securities commissions as a result of the coronavirus (COVID-19) pandemic in respect of the filing of its audited financial statements for the year ended December 31, 2019, and its management’s discussion and analysis for the period. The company said it is continuing to work diligently and expeditiously to file and deliver the filings on or before June 15, 2020. In the interim, it said its management and other insiders of the company are subject to a trading black-out policy. Fura added that since the date of the company's interim financial statements and management’s discussion and analysis for the third quarter of fiscal 2019 no material business developments have occurred aside from those already press released. Internet of Things Inc (CVE:ITT) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on March 12, which will see the issue of 125 million common shares at a purchase price of 1 cent each, together with 125 million share purchase warrants with an exercise price of 5 cents for a period of two years with 51 placees. It noted that should a minimum 1:5 share consolidation occur prior to the warrant conversion, the exercise price will be 5 cents per post-consolidated share. Biocept, Inc. (NASDAQ:BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announced that it will release financial results for the three months ended March 31, 2020, after the market closes on Wednesday, May 13, 2020.  The company also said it will host a conference call for the investment community to discuss the results and answer questions at 4.30pm. Eastern time (1.30pm Pacific time). Individuals interested in participating on the conference call may do so by dialing (855) 656-0927 for domestic callers, (855) 669-9657 for Canadian callers, or (412) 902-4109 for other international callers.  Those interested in listening to a webcast of the live conference call may do so by visiting https://www.webcaster4.com/Webcast/Page/1271/34518. A replay of the conference call will be available for 48 hours following the conclusion of the call by dialing (877) 344-7529 for domestic callers, (855) 669-9658 for Canadian callers, or (412) 317-0088 for other international callers, and entering the replay access code 10143445.  A webcast replay will be available for 90 days at http://ir.biocept.com/events.cfm.